Semi-Annual Consolidated Statement Of Cash Flows

Chordia Therapeutics,Inc - Filing #7339264

Concept As at
2024-02-29
2023-09-01 to
2024-02-29
As at
2023-08-31
2022-09-01 to
2023-08-31
As at
2022-08-31
2021-09-01 to
2022-08-31
As at
2021-08-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,067,245,000 JPY
536,151,000 JPY
-1,718,140,000 JPY
Income taxes paid
-2,420,000 JPY
-2,420,000 JPY
-1,900,000 JPY
Net cash provided by (used in) operating activities
-1,052,483,000 JPY
543,731,000 JPY
-1,704,131,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-178,000 JPY
-347,000 JPY
-8,744,000 JPY
Other, net
1,069,000 JPY
-1,152,000 JPY
Net cash provided by (used in) investing activities
-178,000 JPY
345,000 JPY
-14,696,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
3,975,637,000 JPY
Net cash provided by (used in) financing activities
JPY
JPY
3,975,637,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,052,661,000 JPY
544,077,000 JPY
2,256,809,000 JPY
Cash and cash equivalents
3,746,373,000 JPY
4,799,035,000 JPY
4,254,958,000 JPY
1,998,149,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.